A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

March 18, 2009

HPV Infection Rates High in HIV-Positive MSM

Nearly 100 percent of HIV-positive men who have sex with men (MSM) are infected anally with the human papillomavirus (HPV), and once infected, few are able to clear the virus, according to a study published in the April 1 issue of The Journal of Infectious Diseases and reported by aidsmap.

HPV is a known cause of genital warts and both anal and cervical cancer. Some strains are more likely to cause the warts, while others are likely to lead to cancer. Researchers have previously found high rates of HPV infection among MSM, and even higher rates among HIV-positive men. No large studies, however, have documented changes in infection rates—either acquiring new HPV strains or clearing the virus—over a period of time.

Alexandra de Pokomandy, MD, from the University of Montreal in Canada, set out to do just that, and she and her colleagues enrolled 247 HIV-positive MSM, conducting regular questionnaires, anal swabs and anal biopsies on the participants during an average of three years. The average age of the study participants at study entry was 43, and 38 percent were smokers, which is a known risk factor for cervical cancer in women with HPV infection. On average, the men had been living with HIV for about a decade, and 93 percent were receiving antiretroviral therapy.

Pokomandy and her colleagues found that 98 percent were infected with HPV. Most were infected with multiple strains of HPV, and the majority had at least one strain of the virus associated with anal cancer. The study also found that men continued to become infected with new strains over time. These numbers represent infection rates that are three times higher than in HIV-negative MSM in other studies. Moreover, the authors found that fewer than 13 percent were able to clear HPV infection.

Pokomandy’s team hopes to explore the actual risk of precancerous (dysplasia) and cancerous lesions in this population as the study continues. In the meantime, aidsmap comments that the results reported so far indicate that the new HPV vaccine may have limited benefit in HIV-positive men —it may only be effective for men who have not yet become sexually active with other men.

Search: HPV, human papilloma virus, anal cancer, cervical cancer, men who have sex with men, MSM, Alexandra de Pokamandy, vaccine


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    adoniz89
    san dimas
    California


    sequoiamv
    San Jose
    California


    Fae894
    Coral Springs
    Florida


    jdog46948
    Detroit
    Michigan
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.